John Duncan Higgons

CIK 1581954 · Chief Operating Officer · last filed 2022-06-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.56M

Companies

2

Total Filings

46

Lifetime Open-Market Net

-$21.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Jounce Therapeutics, Inc. (JNCE) Delisted Director 9,713 $1.88 $18.3K $67.9K 12 2022-06-28
AGIO Chief Operating Officer 120,834 $29.46 $3.56M -$21.43M 34 2016-01-05

Recent Filings · Page 2 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-21 Jounce Therapeutics, Inc. (JNCE) Delisted Grant (A) $0 EDGAR
2017-02-02 Jounce Therapeutics, Inc. (JNCE) Delisted Buy (P) +6,700 $107.2K EDGAR
2016-01-05 AGIO Exer (M) +58,999 $195.9K EDGAR
2015-12-17 AGIO Sell (S) −20,000 -$1.00M EDGAR
2015-12-07 AGIO Grant (A) $0 EDGAR
2015-11-18 AGIO Mixed -$1.21M EDGAR
2015-10-19 AGIO Mixed -$1.41M EDGAR
2015-10-09 AGIO Gift (G) −70,000 $0 EDGAR
2015-10-02 AGIO Exer (M) +10,000 $3.0K EDGAR
2015-09-17 AGIO Mixed -$1.82M EDGAR
Showing 1120 of 46
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.